Closely following the announcement of what's to become of the new regulations for telehealth, including ketamine therapy, several of in-clinic treatment centers have announced they are closing their operations.

One of them is the famed Field Trip Health & Wellness Ltd. (OTCMKTS: FTHWF) which, “in an effort to reduce expenditures and preserve capital” will close its facilities in Chicago, Washington DC, Seattle, San Diego and Fredericton, Canada as of April 15, 2023.

Interestingly, not long ago a conference hosted by Cantor Fitzgerald analyst Pablo Zuanic, Chad ketamine therapy companies Field Trip, Irwin Naturals (OTCMKTS: IWINF) and Numinus Wellness (OTCMKTS: NUMIF) shared their views on the ketamine space, Irwin’s CEO praised the value of Field Trip’s offer.

Field Trip …

Full story available on